Status:
COMPLETED
Unipolar vs. Bipolar Hemostasis in Total Knee Arthroplasty: A Prospective Randomized Trial
Lead Sponsor:
Montefiore Medical Center
Conditions:
Knee Arthroplasty
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The use of Aquamantys during total knee arthroplasty will reduce drain output and the necessity for blood transfusions.
Eligibility Criteria
Inclusion
- Patient indicated for total knee arthroplasty
Exclusion
- Patients undergoing revision total knee arthroplasty
- Patients with blood disorders
- Patients on chronic anti-thrombotic medication such as Coumadin
- Patients with a history of deep vein thrombosis
- Patients with a history of pulmonary embolism
Key Trial Info
Start Date :
August 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2010
Estimated Enrollment :
111 Patients enrolled
Trial Details
Trial ID
NCT01003080
Start Date
August 1 2009
End Date
April 1 2010
Last Update
September 21 2018
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Jack D. Weiler Hospital-Division of Montefiore Medical Center
The Bronx, New York, United States, 10461
2
Montefiore Medical Center
The Bronx, New York, United States, 10467